SJS/TEN reactions from CPI therapy can also occur but are extremely rare and it is thought that CD8+ T cells may play a role in the pathogenesis of SJS/TEN in CPI recipients (74–76). This evidence concerns the gene CD8A and Schwartz-Jampel syndrome.